EVA is registered trademark of Stern Stewart.
Economic value added or economic profit is the difference between revenues and costs,where costs include not only expenses, but also cost of capital.
Economic Profit
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 NOPAT. See details »
2 Cost of capital. See details »
3 Invested capital. See details »
4 2017 Calculation
Economic profit = NOPAT – Cost of capital × Invested capital
= 3,274,103 – 10.90% × 37,007,152 = -759,816
- Net Operating Profit After Taxes (NOPAT)
- The net operating profit after taxes displays a generally upward trend from 2013 to 2017. Starting at approximately 1.82 billion USD in 2013, it increased steadily to about 2.29 billion USD by 2015. A significant jump is observed in 2016, where NOPAT reached nearly 3.38 billion USD, followed by a slight decrease in 2017 to around 3.27 billion USD. Overall, the data indicate improving profitability with a peak in 2016.
- Cost of Capital
- The cost of capital maintains relative stability over the examined period. It fluctuates marginally between 10.84% and 11.88%, showing no clear upward or downward trend. This suggests consistent market and financing conditions influencing the company’s capital costs during these years.
- Invested Capital
- Invested capital demonstrates a downward trend from 2013 to 2016. The value decreases from roughly 41.29 billion USD in 2013 to approximately 35.71 billion USD in 2016, reflecting a possible divestment or optimization of capital employed in operations. In 2017, a slight increase is observed, as invested capital rose to about 37.01 billion USD, indicating a potential reinvestment or capital expansion.
- Economic Profit
- Economic profit remains negative throughout the five-year period, indicating that the company’s return did not exceed its cost of capital. However, the magnitude of the negative economic profit decreases significantly over time. Starting at a loss of approximately 3.03 billion USD in 2013, the shortfall narrows to about 759.8 million USD by 2017. This trend implies improving value creation efficiency, although the company has yet to generate positive economic profit.
Net Operating Profit after Taxes (NOPAT)
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 Elimination of deferred tax expense. See details »
2 Addition of increase (decrease) in allowance for doubtful accounts.
3 Addition of increase (decrease) in equity equivalents to net income attributable to Express Scripts.
4 2017 Calculation
Interest expense on capitalized operating leases = Operating lease liability × Discount rate
= 236,952 × 3.81% = 9,028
5 2017 Calculation
Tax benefit of interest expense and other = Adjusted interest expense and other × Statutory income tax rate
= 616,928 × 35.00% = 215,925
6 Addition of after taxes interest expense to net income attributable to Express Scripts.
7 Elimination of discontinued operations.
- Net Income Attributable to Express Scripts
- The net income attributable to the company showed a consistent upward trend throughout the five-year period. Starting from approximately 1.84 billion US dollars in 2013, the net income increased annually, reaching about 4.52 billion US dollars by the end of 2017. This represents a more than doubling of net income over the duration analyzed, indicating strong profitability growth.
- Net Operating Profit After Taxes (NOPAT)
- The NOPAT figures likewise showed an overall increasing trend, rising from roughly 1.82 billion US dollars in 2013 to over 3.27 billion US dollars in 2017. The growth is generally steady, with an especially notable increase between 2015 and 2016. However, unlike net income, NOPAT slightly declined in 2017 compared to the previous year, decreasing from approximately 3.38 billion to 3.27 billion US dollars.
- Comparative Insights
- Both net income and NOPAT demonstrate sustained profitability improvements over the analyzed timeframe, highlighting effective operational and financial management. The disparity in 2017, where net income continued rising but NOPAT decreased, may suggest changes in operating efficiency, tax impact, or other factors affecting post-tax operating profits.
Cash Operating Taxes
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
- Provision for Income Taxes
- The provision for income taxes exhibits fluctuation over the five-year period. It begins at 1,104,000 thousand US dollars at the end of 2013, then decreases slightly in 2014 to 1,031,200 thousand US dollars. A notable increase occurs in 2015, with the provision reaching 1,364,300 thousand US dollars, followed by a decline in 2016 to 999,500 thousand US dollars. By the end of 2017, there is a significant drop to 397,300 thousand US dollars, marking the lowest figure in the observed timeframe.
- Cash Operating Taxes
- Cash operating taxes demonstrate more variability with an overall upward trajectory throughout the period. Starting at 1,890,614 thousand US dollars in 2013, the amount decreases to 1,669,615 thousand US dollars in 2014. Subsequently, a sharp increase is observed in 2015, reaching 2,004,540 thousand US dollars. In 2016, cash operating taxes decline again to 1,743,214 thousand US dollars before climbing significantly to 2,292,125 thousand US dollars by the end of 2017, the highest level recorded in the five years.
- Comparative Observations
- Overall, the provision for income taxes and cash operating taxes do not follow the same trend patterns. While the provision for income taxes peaks in 2015 before steadily declining to its lowest point in 2017, cash operating taxes show a general increasing trend despite year-to-year fluctuations. The divergence between these two tax-related metrics may suggest differences in tax accounting policies, timing differences, or changes in cash flow management relating to tax obligations.
Invested Capital
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 Addition of capitalized operating leases.
2 Elimination of deferred taxes from assets and liabilities. See details »
3 Addition of allowance for doubtful accounts receivable.
4 Addition of equity equivalents to total Express Scripts stockholders’ equity.
5 Removal of accumulated other comprehensive income.
- Total Reported Debt & Leases
- The total reported debt and leases show a fluctuating trend over the five-year period. The value decreased slightly from approximately 14.27 billion USD at the end of 2013 to about 13.86 billion USD in 2014. However, from 2014 onward, the debt increased steadily, reaching around 16.25 billion USD by the end of 2017. This reflects a rising leverage position in the latter years.
- Total Express Scripts Stockholders’ Equity
- Stockholders’ equity demonstrates a declining trend from 2013 through 2016, dropping from roughly 21.84 billion USD in 2013 to about 16.24 billion USD in 2016. This decline represents a significant reduction in equity over this period. Notably, in 2017, there is a reversal of this downward trend with equity increasing to about 18.12 billion USD, suggesting a partial recovery or accumulation of retained earnings or capital injection during that year.
- Invested Capital
- Invested capital also declined consistently from 2013 to 2016, moving from approximately 41.29 billion USD to around 35.71 billion USD. In 2017, a modest increase to about 37.01 billion USD is observed. This trend indicates a contraction in the total capital employed by the company initially, followed by a slight expansion towards the end of the period.
Cost of Capital
Express Scripts Holding Co., cost of capital calculations
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 44,380,248) | 44,380,248) | ÷ | 60,978,400) | = | 0.73 | 0.73 | × | 14.05% | = | 10.23% | ||
Debt3 | 16,361,200) | 16,361,200) | ÷ | 60,978,400) | = | 0.27 | 0.27 | × | 3.81% × (1 – 35.00%) | = | 0.66% | ||
Operating lease liability4 | 236,952) | 236,952) | ÷ | 60,978,400) | = | 0.00 | 0.00 | × | 3.81% × (1 – 35.00%) | = | 0.01% | ||
Total: | 60,978,400) | 1.00 | 10.90% |
Based on: 10-K (reporting date: 2017-12-31).
1 US$ in thousands
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 42,176,284) | 42,176,284) | ÷ | 58,225,826) | = | 0.72 | 0.72 | × | 14.05% | = | 10.18% | ||
Debt3 | 15,808,800) | 15,808,800) | ÷ | 58,225,826) | = | 0.27 | 0.27 | × | 3.72% × (1 – 35.00%) | = | 0.66% | ||
Operating lease liability4 | 240,743) | 240,743) | ÷ | 58,225,826) | = | 0.00 | 0.00 | × | 3.72% × (1 – 35.00%) | = | 0.01% | ||
Total: | 58,225,826) | 1.00 | 10.84% |
Based on: 10-K (reporting date: 2016-12-31).
1 US$ in thousands
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 45,861,358) | 45,861,358) | ÷ | 62,116,744) | = | 0.74 | 0.74 | × | 14.05% | = | 10.37% | ||
Debt3 | 15,988,600) | 15,988,600) | ÷ | 62,116,744) | = | 0.26 | 0.26 | × | 3.25% × (1 – 35.00%) | = | 0.54% | ||
Operating lease liability4 | 266,786) | 266,786) | ÷ | 62,116,744) | = | 0.00 | 0.00 | × | 3.25% × (1 – 35.00%) | = | 0.01% | ||
Total: | 62,116,744) | 1.00 | 10.93% |
Based on: 10-K (reporting date: 2015-12-31).
1 US$ in thousands
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 63,036,595) | 63,036,595) | ÷ | 77,531,603) | = | 0.81 | 0.81 | × | 14.05% | = | 11.42% | ||
Debt3 | 14,200,200) | 14,200,200) | ÷ | 77,531,603) | = | 0.18 | 0.18 | × | 3.78% × (1 – 35.00%) | = | 0.45% | ||
Operating lease liability4 | 294,809) | 294,809) | ÷ | 77,531,603) | = | 0.00 | 0.00 | × | 3.78% × (1 – 35.00%) | = | 0.01% | ||
Total: | 77,531,603) | 1.00 | 11.88% |
Based on: 10-K (reporting date: 2014-12-31).
1 US$ in thousands
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Capital (fair value)1 | Weights | Cost of capital | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity2 | 59,847,588) | 59,847,588) | ÷ | 74,732,117) | = | 0.80 | 0.80 | × | 14.05% | = | 11.25% | ||
Debt3 | 14,562,800) | 14,562,800) | ÷ | 74,732,117) | = | 0.19 | 0.19 | × | 3.80% × (1 – 35.00%) | = | 0.48% | ||
Operating lease liability4 | 321,730) | 321,730) | ÷ | 74,732,117) | = | 0.00 | 0.00 | × | 3.80% × (1 – 35.00%) | = | 0.01% | ||
Total: | 74,732,117) | 1.00 | 11.74% |
Based on: 10-K (reporting date: 2013-12-31).
1 US$ in thousands
2 Equity. See details »
3 Debt. See details »
4 Operating lease liability. See details »
Economic Spread Ratio
Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Economic profit1 | (759,816) | (497,437) | (1,797,376) | (2,636,082) | (3,031,422) | |
Invested capital2 | 37,007,152) | 35,712,343) | 37,411,086) | 38,622,209) | 41,289,230) | |
Performance Ratio | ||||||
Economic spread ratio3 | -2.05% | -1.39% | -4.80% | -6.83% | -7.34% | |
Benchmarks | ||||||
Economic Spread Ratio, Competitors4 | ||||||
Abbott Laboratories | — | — | — | — | — | |
Elevance Health Inc. | — | — | — | — | — | |
Intuitive Surgical Inc. | — | — | — | — | — | |
Medtronic PLC | — | — | — | — | — | |
UnitedHealth Group Inc. | — | — | — | — | — |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 Economic profit. See details »
2 Invested capital. See details »
3 2017 Calculation
Economic spread ratio = 100 × Economic profit ÷ Invested capital
= 100 × -759,816 ÷ 37,007,152 = -2.05%
4 Click competitor name to see calculations.
- Economic Profit
- The economic profit exhibits a consistent improvement over the five-year period. Starting at a substantial negative value in 2013, the loss decreases year by year, reaching its lowest negative figure in 2016. Although there is a slight decline in performance in 2017 compared to 2016, the overall trend reflects a significant reduction in economic loss, indicating progress toward profitability.
- Invested Capital
- The invested capital shows a decreasing trend from 2013 through 2016, suggesting a reduction in capital investment or asset base. In 2017, there is a minor increase in invested capital, indicating a potential shift in strategy or an expansion after a period of contraction.
- Economic Spread Ratio
- The economic spread ratio demonstrates a steady improvement across the timeline, moving from a highly negative percentage in 2013 towards a less negative value in 2017. This ratio indicates narrowing losses relative to invested capital, with the steepest improvement observed between 2015 and 2016. The slight increase in the negative spread in 2017 suggests some challenges in maintaining this positive trajectory.
Economic Profit Margin
Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in thousands) | ||||||
Economic profit1 | (759,816) | (497,437) | (1,797,376) | (2,636,082) | (3,031,422) | |
Revenues | 100,064,600) | 100,287,500) | 101,751,800) | 100,887,100) | 104,098,800) | |
Performance Ratio | ||||||
Economic profit margin2 | -0.76% | -0.50% | -1.77% | -2.61% | -2.91% | |
Benchmarks | ||||||
Economic Profit Margin, Competitors3 | ||||||
Abbott Laboratories | — | — | — | — | — | |
Elevance Health Inc. | — | — | — | — | — | |
Intuitive Surgical Inc. | — | — | — | — | — | |
Medtronic PLC | — | — | — | — | — | |
UnitedHealth Group Inc. | — | — | — | — | — |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 Economic profit. See details »
2 2017 Calculation
Economic profit margin = 100 × Economic profit ÷ Revenues
= 100 × -759,816 ÷ 100,064,600 = -0.76%
3 Click competitor name to see calculations.
- Economic Profit
- The economic profit demonstrated a consistent improvement over the examined period. Starting from a significant negative value of -3,031,422 thousand US dollars at the end of 2013, there was a steady reduction in the loss each year, reaching -497,437 thousand US dollars by the end of 2016. However, in 2017, a slight deterioration was observed as the economic profit moved back to -759,816 thousand US dollars, indicating a reversal in the positive trend.
- Revenues
- Revenues showed relative stability throughout the five-year period. Beginning at 104,098,800 thousand US dollars in 2013, revenues experienced minor fluctuations but generally maintained a level slightly above 100 billion US dollars each year. The highest revenue occurred in 2013, and by 2017, it had marginally decreased to 100,064,600 thousand US dollars, indicating limited revenue growth or decline over the timeframe.
- Economic Profit Margin
- The economic profit margin mirrored the trend observed in economic profit, with an overall improvement from negative 2.91% in 2013 to negative 0.5% in 2016, reflecting an enhanced ability to generate profit relative to the economic capital employed. However, in 2017, the margin slightly worsened to negative 0.76%, showing a minor retreat from the previous year's progress. This marginal improvement over the years suggests some operational or cost-related enhancements but ongoing challenges in achieving positive economic profitability.
- Overall Insights
- Over the five-year period, the company experienced a clear trend toward improving economic profitability as indicated by reductions in economic losses and enhancing economic profit margins. Revenues remained stable, implying that the improvements were likely driven by cost management or operational efficiencies rather than top-line growth. The slight setback in 2017 in both economic profit and profit margin points to potential challenges needing further attention to sustain or accelerate profitability gains.